amgen glp-1 A GIPR antagonist conjugated to analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Amgen (AMGN) Expands Obesity Strategy

Learn the most common GLP-1 side effects and how to manage them with dose adjustments, lifestyle tips, and guidance from your provider and Noom.

Reduce hunger* Contains Supresa, a patented saffron extract shown to reduce snacking and decrease hunger, with 69% of participants reporting reduced hunger within 8 weeks

Differences between agents highlight the importance of individualized treatment strategies, complemented by nutritional and exercise interventions to optimize long-term outcomes.

Both tirzepatide (since 2022) and semaglutide (since 2024) were placed on the shortage list, prompting a surge in sales of compounded alternatives

Akkermansia muciniphila

Discover differences in offerings, pricing, shipping, and support to find the best fit for your health needs.